Cardiovascular medication :: Consumers survey results of for 1 quarter of 2016

Consumers survey results of for 1 quarter of 2016 in category

Circulatory system / Cardiovascular medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	5	Валідол-Дарниця (Darnitsa)	35.71%	5

1.	5	Кардіомагніл (Nycomed)	35.71%	5

3.		Validol (Farmak)	28.57%	4

3.	9	Трикардин (Ternopharm)	28.57%	4

5.	2	Аспаркам (Arterium Corporation)	21.43%	3

5.		Валідол (Лубнифарм)	21.43%	3

5.	1	Корвалмент (Київський вітамінний завод)	21.43%	3

5.	6	Корвалтаб (Фарма Старт)	21.43%	3

9.		Aspirin cardio (Bayer)	14.29%	2

9.	5	Нітрогліцерин (Технолог)	14.29%	2

11.	8	Аспекард (Стиролбіофарм)	7.14%	1

11.	9	Вітрум кардіо / Вітрум кардіо Омега-3 (Такеда)	7.14%	1

11.	8	Глоду настоянка (Лубнифарм)	7.14%	1

11.	6	Глоду настоянка (Ternopharm)	7.14%	1

11.	7	Кратал (Борщагівський ХФЗ)	7.14%	1

11.	6	Панангін (Gedeon Richter)	7.14%	1

11.	4	Пумпан (Perrigo)	7.14%	1

–.	10	АТФ-Лонг (Фаркос)	0.00%	0

–.		АТФ-Лонг (Борщагівський ХФЗ)	0.00%	0

–.		Екорін (USV Limited)	0.00%	0

–.		Кардіплант (Schwabe)	0.00%	0

–.	10	Кардио-гран (Національна гомеопатична спілка)	0.00%	0

–.	8	Кверцетин (Борщагівський ХФЗ)	0.00%	0

–.		Кралонін (Heel)	0.00%	0

–.	7	Краплі Зеленіна (Фітофарм)	0.00%	0

–.		Ритмокор (Фаркос)	0.00%	0

–.	10	Хомвіокорин-N (Homviora Arzneimittel)	0.00%	0

–.		Хомвіотензин (Homviora Arzneimittel)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2016, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.